Surgical Treatment in Papillary Thyroid Microcarcinom

Tunca F., Sormaz I. C., İşcan A. Y., Senyurek Y.

MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, cilt.52, sa.4, ss.244-248, 2018 (ESCI) identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 52 Sayı: 4
  • Basım Tarihi: 2018
  • Doi Numarası: 10.14744/semb.2018.45452
  • Dergi Adı: MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.244-248
  • Anahtar Kelimeler: Papillary thyroid microcarcinoma, surgery, ACTIVE SURVEILLANCE, ASSOCIATION GUIDELINES, CARCINOMA, MANAGEMENT, CANCER, RISK, LOBECTOMY
  • İstanbul Üniversitesi Adresli: Evet

Özet

Despite the notable increasing incidence of papillary thyroid microcarcinoma (PTMC), the optimal treatment of the patients with PTMC remains controversial. Because of no consensus about its treatment, the suggested treatment varies from active surveillance alone to total thyroidectomy. Although the 2015 revised American Thyroid Association guideline recommends hemithyroidectomy as the first-line treatment, active surveillance has also been discussed and accepted as another approach for the patients with PTMC. However, the same guideline does not recommend fine needle aspiration biopsy for nodules sized <1 cm, even it is suspicious. In such situation, neither active surveillance nor hemithyroidectomy could be discussed, with a lack of objective cytologic data about the nodules sized <1 cm. In this situation, the decision to perform FNAB to the nodules <1 cm in size depends on the performer of the thyroid ultrasonography.